(Reuters) - Genetic testing specialist Qiagen’s Chief Executive Thierry Bernard said the…
Super UserFebruary 16, 2021
U.S. drug maker Emergent BioSolutions began speeding up its acquisition of drug…
Super UserFebruary 16, 2021
The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung,…
Super UserFebruary 16, 2021
The Port Covington Development Team consisting of lead investors Sagamore Ventures and…
Super UserFebruary 16, 2021
University System of Maryland (USM) asked members of its community to get…
Super UserFebruary 16, 2021
GAITHERSBURG, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc., a clinical-stage…
Super UserFebruary 16, 2021